Quick Answer
BetterLife Pharma Inc. reported Operating Income of -$6.84 million for fiscal year 2019.
BetterLife Pharma Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2019 | -$6.84M | -405.1% |
| 2018 | -$1.35M | +77.5% |
| 2017 | -$6.02M | +41.6% |
| 2016 | -$10.32M | -8685.4% |
| 2015 | -$117.5K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| April 30, 2019 | -$1.66M | +11.5% | -17.7% |
| October 31, 2018 | -$1.41M | -664.6% | -19.5% |
| July 31, 2018 | -$1.18M | -374.8% | +37.1% |
| April 30, 2018 | -$1.88M | -557.7% | -917.0% |
| October 31, 2017 | -$184.7K | +73.2% | +25.8% |
| July 31, 2017 | -$248.8K | +78.9% | +12.9% |
| April 30, 2017 | -$285.5K | +91.4% | +58.6% |
| October 31, 2016 | -$690.3K | -8702.7% | +41.5% |
- BetterLife Pharma Inc. showed a decrease of -405.1% in Operating Income compared to the prior fiscal year.
- Over the 2015–2019 period, BetterLife Pharma Inc.’s operating income has declined by 5725.6% (from -$117.5 thousand to -$6.84 million).
- The most recent figure is from BetterLife Pharma Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on May 3, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: